An Audit of Emergency Group O blood use in Royal Devon and Exeter Hospital

Similar documents
BLOOD COMPONENT SUPPORT OF RhD NEGATIVE INDIVIDUALS

Essentials of Blood Group Antigens and Antibodies

BCSH Appropriate Use of O Neg. Dr Megan Rowley Consultant In Transfusion Medicine SNBTS at the Royal Infirmary of Edinburgh

Transfusion Awareness

HOW RARE IS YOUR BLOOD? DONATE ( ) CANADIAN BLOOD SERVICES RARE BLOOD PROGRAM

National Comparative Audit of Blood Transfusion Audit of Red Cell & Platelet Transfusion in Adult Haematology Patients.

Hot topics in Paediatric Transfusion and the Emergency Provision from the Blood Transfusion Laboratory. Margaret Slade

The testing of Donated Blood and Components at NHSBT

The Experience in Exeter with. hip fracture care. Data For Change

Great Ormond Street Hospital for Children. Patient Transfer. Penny Eyton-Jones TLM, Great Ormond Street NHS Foundation Trust

Patient Information. Tension Free Vaginal/ Obturator Tape (TVT) Royal Devon and Exeter NHS Foundation Trust

National Comparative Audit of Blood Transfusion Re-audit of the Use of Group O RhD Negative Red Cells

Summary of Significant Changes

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant. Lab Matters study day Oake Manor, Taunton, 8 th July 2015

Non-Medical Authorisation Course

MASSIVE HAEMORRHAGE J DAVIES ROYAL DEVON AND EXETER NHS FOUNDATION TRUST. Respond Deliver & Enable

BLOOD GROUPS TOPIC IN BLOOD GROUPS: ABO BLOOD GROUP SYSTEM, RH SYSTEM AND RED KENDRIYA VIDYALAYA NELLORE DATE & TIME: 7 TH APRIL 2018

Audit of Platelet Use

Hepatitis E and the English blood supply

Consultation and Investigations

Organ Donation Annual Report. April 2011 to March 2012.

Transfusion Reactions. Megan Rowley and Peter Struik

North West Regional Transfusion Committee Audit of Platelet Use and Wastage

SWARM Perioperative Regional Anaesthetic Techniques Survey SPRATS. Lead Investigators Dr T Wilson and Dr M Rockett

Blood Types and Genetics

Special Requirements Lab Matters. 18 th May Katy Cowan PBM Practitioner NHSBT

Document for Obstetric Patients Who Refuse Consent for Blood and Blood Product Administration, Including Jehovah s Witnesses

A review of paediatric and neonatal prescribing practice. Tracey Shackleton Alder Hey Children s NHS Trust 24 th September 2014

You can save even more lives. Join the British Bone Marrow Registry

Transfusion support during Mass Casualty Events

HAEMOGLOBINOPATHY PATIENT GENOTYPING

Organ Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities. Report for 2015/2016 (1 April March 2016)

Transfusion-transmitted HIV from seroconverted blood donors has not been identified in England since the introduction of HIV NAT screening

Therapeutic Apheresis Services Annual Review 2016/17

Jo Shorthouse. With thanks to Dr Kate Pendry. Consultant Haematologist Central Manchester Hospitals. and. Clinical Director for PBM NHSBT

Liver biopsy. Information for patients Hepatobiliary

The need for a Soft Opt-out Plus approach to the proposed change in organ donor consent Ireland.

MINUTES OF THE SOUTH-EAST COAST REGIONAL TRANSFUSION TEAM MEETING. By telecon. 14 November 2017

Preoperative Fasting Policy for Adults and Children

Title: Blood Transfusion Laboratory User Handbook

Transfusion Errors in Transplant Recipients. Paula Bolton-Maggs Alison Watt Debbi Poles Serious Hazards of Transfusion

HLA Selected Platelets

Major Blood Loss (MBL) Dicing With Death. Tracey McConnell Senior BMS NNUH

BMS Education Day 28 th January and 4th February 2013

New recommendations for immunocompromised patients

Supporting solid organ transplants: Challenges for Blood Transfusion Labs

Hip hemi-arthroplasty

NHSBT Board. Clinical Governance Report 01 October - 30 November 2016

Organ Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities. Report for 2016/2017 (1 April March 2017)

Organ Donation and Transplantation data for Black, Asian and Minority Ethnic (BAME) communities. Report for 2017/2018 (1 April March 2018)

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org

Special Requirements Lab Matters. 21 st June Barrie Ferguson

Newcastle upon Tyne Blood Transfusion Course

Better Blood Transfusion Level 2 BLOOD COMPONENT USE. Self-Directed Learning Pack

Information for patients with Sickle Cell Disease who may need a blood transfusion. Patient information

Dr Megan Rowley. CONSULTANT HAEMATOLOGIST - NHSBT and Imperial

lnhs BLOOD AND TRANSPLANT RESEARCH, INNOVATION AND NOVEL TECHNOLOGIES ADVISORY GROUP DCD HEART ACTIVITY

Brief Audit of Platelet Use in the Yorkshire and The Humber Region

ALL Blood Transfusion samples must be hand-written in accordance with the Trust's Blood Administration Protocol

The use of red cell genotyping in the management of sickle cell disease

All you wanted to know about transfusion support for transplants

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood.

A30-year-old G2P1 female is 12 weeks pregnant

out of hours donor frozen section

Guidelines for Requesting Type and Screen Testing for Elective Surgical Adult Patients within the WRHA Surgery Program

Impact of the Human Transplantation Act (Wales)

Numerous clinical situations require emergent

Oxford Transplant Centre. Live donor kidney transplantation what if we are not a match?

Survey of Massive Blood Loss In the North East of England 2013

Document Control Report

Choosing Wisely YouTube video

Blood Component Testing and Labeling

Working Together to Support Dementia: The STEMS Model

W A Flegel Florianopolis 11 Nov General aspects and advances in RH and other blood groups. RHCE: ancestral position RHD is the duplicated gene

Plasma for fractionation: South African Plasma Requirements

Blood Groups. Prepared by the one and only Mr.Yeung BIO30S

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

Guide to the preparation, use and quality assurance of blood components

Database on Blood Safety 2009 in ECO Member States

Manchester Royal Infirmary Renal & Pancreas Transplant Unit / 2012 Activity Annual Report

Blood Groups. Prepared by the one and only Mr.Yeung BIO30S

WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years

Recipients and Recipient Transplant Coordinators. April 2014 Helen Tincknell Lead Nurse Recipient Coordination NHSBT

CURRENT COURSE OFFERINGS

CTYOMEGALOVIRUS (CMV) - BACKGROUND

Blood Conservation. To introduce the learner to the basic concepts of blood conservation!! Learning Outcomes

Blood Supply and Wastage

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

Why the Hospital Transfusion laboratory may challenge the use of O D negative blood in an emergency.

And anti-b

2016 Re-Audit of Patient Blood Management in adults undergoing elective, scheduled surgery

Revised November 2012

All institutions that transfuse blood components and products should implement national and local policies and written procedures for:

Julie Ball SHOT Clinical Incidents Specialist

Pearce, Catharine. Downloaded 22-Oct :14:

*Serology. Dr. Geoffrey H. Tovey, M.D. present in the plasma (see Fig. I). The Rh factor differs from the A and B factors. Fig. I.

PATIENT SAFETY ALERT

Overview of Organ Donation and Transplantation

Transcription:

An Audit of Emergency Group O blood use in Royal Devon and Exeter Hospital Jack Cunningham Keira Soanes

Why are we looking at our use of Emergency Group O RhD negative blood? Following the NHSBT National Audit and re-audit of the use of O RhD negative red cells (2008 and 2010) and based on current prevalence of group O RhD negative in the population a national target of 10.5% of total red cell stock was set for hospitals. As a hospital, the RD&E are running just below this recommended stock level.

On average each O RhD negative blood donor donates 20% more blood than other donor groups

Blood Stocks: A typical picture

NHSBT 2014 Laboratory Managers Survey found that 58% of Trusts had a policy for using O Rh Positive blood in adult males of unknown blood group. We don t, should we?

Audit We searched the LIMS system for all emergency Group O RhD negative uncrossmatched units issued at the RD&E during 2015. We then searched each patient by hospital number in the pathology system to find out out how many units of uncrossmatched group O RhD Negative units they received within a 24hr period We also examined whether each patient received any additional cross matched units within that same 24hour period.

Results of Audit 49 Patients required Emergency Group O RhD blood in 2015 in the RD&E 97 units of Emergency Group O RhD Negative blood were transfused Average of 1.97 units per patient

Where were these O RhD Negative red cells used? Where? How many units? Percentage of total use Emergency Department 34 34% ITU 30 31% Surgical Wards 11 11% Medical Wards 6 7% Medical Triage/AMU 5 5% Neonatal Unit 6 6% Labour Ward 3 3% Theatre Main 1 1%

Possible Strategies for conserving Group O RhD negative emergency stocks 1. Use a maximum of 2 units of O RhD negative blood in all cases and then move to O RhD positive blood after this in women over 60 and men over 18. This would save 14 units of O RhD negative blood per year 2. Group O RhD positive blood for women aged over 60 and men over age of 18. This would save 71 units of O RhD negative blood per year

Serological Risk: What are the risks of transfusing O Rh D positive blood to Rh D negative recipients? Risk of Transfusion Reactions Transfusing a RhD negative patient who already has Anti RhD antibodies Does this matter clinically? Risk of antibody formation Risk of RhD antibodies developing in RhD negative patients. Not a concern unless in the future the patient needs a second emergency transfusion with RhD positive blood. Does this matter clinically?

What is risk of giving RhD negative patients Anti RhD antibodies? 36/49 patients would have fulfilled criteria to receive Group O RhD positive blood & 6 of these patients were Group O RhD negative. Of the patients receiving Emergency Group O RhD Negative blood, 25 % died, leaving 4.5 patients alive and at risk of developing Anti RhD antibodies. We estimate that in our population about 50% of RhD negative patients given a RhD positive transfusion will develop Anti D. So by changing policy, we risk giving 2 people anti D antibodies. Is it worth this risk?

System and Human Error Risk of a RhD negative woman of child bearing age receiving Group O RhD positive blood Risk of delay in provision of emergency blood through confusion with new policy The RD&E HTT felt that there was a risk of giving a RhD negative woman of childbearing age RhD positive blood and so a third strategy is being considered; using Group O Positive blood for all males over 18 but not for women.

How much Group O RhD negative blood would we save with 3rd option? using Group O Positive blood for all males over 18 but not for women In 2015, a total of 54 Group O RhD negative units would have been saved.

What do you think?